| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f8d9aa0ec027f49423d83ad94f357f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59a80251f96e0da27d327e0a7539e7d7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
| filingDate |
2022-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_539e3f0dc0897d2089c2030b3c58b745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dd86f9b589d714e4e59879ca1871846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bd3c2752c0fcb003fb5a3396795b38a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3c259743fbb714dd8ad192f79127619 |
| publicationDate |
2022-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022199685-A1 |
| titleOfInvention |
Nucleic acid molecule conjugate having prolonged in vivo half-life |
| abstract |
A nucleic acid molecule conjugate having a prolonged in vivo half-life. The nucleic acid molecule is conjugated to a fatty acid and a coumarin derivative. More specifically, the nucleic acid molecule is an aptamer, in particular an aptamer against sclerostin. |
| priorityDate |
2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |